{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:16:36Z","timestamp":1782774996102,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.rdc.2016.12.008","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T02:00:19Z","timestamp":1489456819000},"page":"201-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Biomarkers for Adverse Pregnancy Outcomes in Rheumatic Diseases"],"prefix":"10.1016","volume":"43","author":[{"given":"May Ching","family":"Soh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nelson-Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.rdc.2016.12.008_bib1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.rdc.2016.12.008_bib2","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/art.39218","article-title":"Association between pregnancy outcomes and cardiovascular deaths in women with systemic lupus erythematosus utilising Swedish population registries","volume":"67","author":"Soh","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.008_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/HJH.0b013e3282f1a953","article-title":"Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension","volume":"26","author":"Homer","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.rdc.2016.12.008_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1741-7015-7-10","article-title":"Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review","volume":"7","author":"Thangaratinam","year":"2009","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.008_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1600-0897.2010.00831.x","article-title":"Immunology of pre-eclampsia","volume":"63","author":"Redman","year":"2010","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.008_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.preghy.2010.12.003","article-title":"Pre-eclampsia: definitions, paternal contributions and a four stage model","volume":"1","author":"Redman","year":"2011","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.008_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.preghy.2014.04.020","article-title":"The six stages of pre-eclampsia","volume":"4","author":"Redman","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"Suppl","key":"10.1016\/j.rdc.2016.12.008_bib8","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.008_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/uog.13310","article-title":"Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia","volume":"44","author":"Verlohren","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.008_bib10","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/1471-0528.12677","article-title":"Maternal obesity and excess of fetal growth in pre-eclampsia","volume":"121","author":"Rasmussen","year":"2014","journal-title":"BJOG"},{"issue":"7627","key":"10.1016\/j.rdc.2016.12.008_bib11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/bmj.39366.416817.BE","article-title":"Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study","volume":"335","author":"Magnussen","year":"2007","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.008_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.110.943407","article-title":"Hypertension in pregnancy and later cardiovascular risk: common antecedents?","volume":"122","author":"Romundstad","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.008_bib13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20132011 update: a guideline from the American Heart Association","volume":"57","author":"Mosca","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.rdc.2016.12.008_bib14","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.placenta.2011.11.005","article-title":"The feto-placental unit, pregnancy pathology and impact on long term maternal health","volume":"33","author":"Clifton","year":"2012","journal-title":"Placenta"},{"issue":"Suppl A","key":"10.1016\/j.rdc.2016.12.008_bib15","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.placenta.2007.11.016","article-title":"Circulating microparticles in normal pregnancy and pre-eclampsia","volume":"29","author":"Redman","year":"2008","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.008_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/OGX.0b013e3182227027","article-title":"Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review","volume":"66","author":"Kuc","year":"2011","journal-title":"Obstet Gynecol Surv"},{"issue":"9","key":"10.1016\/j.rdc.2016.12.008_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrneph.2014.103","article-title":"Pre-eclampsia part 2: prediction, prevention and management","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"4 Suppl","key":"10.1016\/j.rdc.2016.12.008_bib18","doi-asserted-by":"crossref","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"24","key":"10.1016\/j.rdc.2016.12.008_bib19","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.rdc.2016.12.008_bib20","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.rdc.2016.12.008_bib21","first-page":"E1","article-title":"Plasma Placental Growth Factor (PlGF) in the diagnosis of women with pre-eclampsia requiring delivery within 14\u00a0days","volume":"120","author":"Duckworth","year":"2013","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.008_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2015.10.003","article-title":"Soluble endoglin, hypercholesterolemia and endothelial dysfunction","volume":"243","author":"Rathouska","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.008_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/uog.7491","article-title":"Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations","volume":"35","author":"Chaiworapongsa","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.008_bib24","doi-asserted-by":"crossref","first-page":"e48259","DOI":"10.1371\/journal.pone.0048259","article-title":"Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia","volume":"7","author":"Rana","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.rdc.2016.12.008_bib25","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","volume":"29","author":"Chaiworapongsa","year":"2015","journal-title":"J\u00a0Maternal Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.008_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2016.12.008_bib27","unstructured":"The National Institute for Health and Care Excellence (NICE). PlGF-based testing to help diagnose suspected pre-eclampsia. (Diagnostic Guidance) 2016."},{"issue":"4","key":"10.1016\/j.rdc.2016.12.008_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","article-title":"Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease","volume":"89","author":"Bramham","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.008_bib29","first-page":"631","article-title":"Soluble fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus","volume":"35","author":"Qazi","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.008_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3899\/jrheum.141571","article-title":"Circulating angiogenic factors and the risk of preeclampsia in systemic lupus erythematosus pregnancies","volume":"42","author":"Leanos-Miranda","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.008_bib31","doi-asserted-by":"crossref","first-page":"108.e1-e14","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Suppl","key":"10.1016\/j.rdc.2016.12.008_bib32","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ajog.2015.08.015","article-title":"How the placenta affects your life, from womb to tomb","volume":"213","author":"Nelson","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Suppl","key":"10.1016\/j.rdc.2016.12.008_bib33","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ajog.2015.08.030","article-title":"The placenta is the center of the chronic disease universe","volume":"213","author":"Thornburg","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"7627","key":"10.1016\/j.rdc.2016.12.008_bib34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.rdc.2016.12.008_bib35","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1161\/CIRCULATIONAHA.111.034884","article-title":"Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth","volume":"124","author":"Bonamy","year":"2011","journal-title":"Circulation"},{"issue":"9499","key":"10.1016\/j.rdc.2016.12.008_bib36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(05)67726-4","article-title":"Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study","volume":"366","author":"Ray","year":"2005","journal-title":"Lancet"},{"issue":"8858","key":"10.1016\/j.rdc.2016.12.008_bib37","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/0140-6736(93)90889-O","article-title":"Pre-eclampsia: more than pregnancy-induced hypertension","volume":"341","author":"Roberts","year":"1993","journal-title":"Lancet"},{"issue":"9249","key":"10.1016\/j.rdc.2016.12.008_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.008_bib39","doi-asserted-by":"crossref","first-page":"526.e1-e8","DOI":"10.1016\/j.ajog.2011.02.016","article-title":"Cardiovascular risk factors prior to conception and the length of pregnancy: population-based cohort study","volume":"204","author":"Magnussen","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.008_bib40","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.placenta.2008.08.018","article-title":"The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia","volume":"29","author":"Reddy","year":"2008","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.008_bib41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/acr.20122","article-title":"Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus","volume":"62","author":"Urowitz","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.008_bib42","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/kew043","article-title":"Maternal-placental syndrome and future risk of accelerated cardiovascular events in parous Swedish women with systemic lupus erythematosus\u2014a population-based retrospective cohort study with time-to-event analysis","volume":"55","author":"Soh","year":"2016","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:16:50Z","timestamp":1760181410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16301119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0889857X16301119"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for Adverse Pregnancy Outcomes in Rheumatic Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}